Company / Operating Income per Share
Verrica Pharmaceuticals Inc. Operating Income per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$7.18
FY2025
5-year range
-$7.18 / -$0.52
FY2021-FY2025
Trend
-363.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed -363% YoY in FY2025, a notable deviation from the 4-year average annual change of -120%.
Based on SEC 10-K filings.
-7.18 in FY2025.
Declined from $-0.52 to $-7.18 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share decreased 363.2% year-over-year.
- Peak operating income per share was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -3.86 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$7.18 | -363.2% |
| FY2024 | -$1.55 | -199.2% |
| FY2023 | -$0.52 | +53.9% |
| FY2022 | -$1.12 | +28.9% |
| FY2021 | -$1.58 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026